StockData

Oaktree Acquisition Corp. III Life Sciences (OACC) stock

OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026
$10.72+0.02 (+0.19%)

Close on Nov 17, 2026Market cap $263.53MP/E –Yield –

Oaktree Acquisition Corp. III Life Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Oaktree Acquisition Corp. III Life Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$455.69K. For fiscal 2025 it was -$422.08K.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$422.08K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$97.26K–
Q1 FY2026Mar 31, 2026-$158.04K–
Q4 FY2025Dec 31, 2025-$143.88K–
Q3 FY2025Sep 30, 2025-$56.52K–
Q2 FY2025Jun 30, 2025-$146.12K–
Q1 FY2025Mar 31, 2025-$75.56K–
Q3 FY2024Sep 30, 2024$0–

More Oaktree Acquisition Corp. III Life Sciences figures

See a number that looks wrong?